Clinical Trials Browser

Withdrawn × Endometrial Neoplasms × Bevacizumab × Clear all

NCT03836157 2019-06-27

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Phase 2 Withdrawn

Endometrial Neoplasms